Selective localization of T helper subsets in labial salivary glands from primary Sjögren's syndrome patients. 2012

T Maehara, and M Moriyama, and J-N Hayashida, and A Tanaka, and S Shinozaki, and Y Kubo, and K Matsumura, and S Nakamura
Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Higashi-ku, Fukuoka, Japan.

The aim of this study was to investigate the initiation and progression of autoimmune damage in the lesions of labial salivary glands (LSGs) from primary Sjögren's syndrome (SS) patients by examining the selective localization of T helper (Th) subsets such as Th1, Th2, Th17 regulatory T cells (T(regs)) and follicular T helper cells (Tfh). The expression of cytokines and transcription factors associated with these Th subsets in the LSGs from 54 SS patients and 16 healthy controls was examined using real-time polymerase chain reaction (PCR) and immunostaining. Additionally, infiltrating lymphocytes without germinal centre (GC(-)) and with GC (GC(+)) in the LSGs specimens from eight SS patients were extracted selectively by laser capture microdissection (LCM). The mRNA expression of these molecules was compared between the two sample groups of GC(-) and GC(+) by real-time PCR. The mRNA expression of cytokines and transcription factors of all T helper (Th) subsets in the LSGs from the SS patients was increased significantly in comparison with controls. In LSGs from the SS patients, Th2 and Tfh was associated closely with strong lymphocytic infiltration; however, Th1, Th17 and T(regs) was not. In the selectively extracted lesions of LSGs, Th1 and Th17-related molecules were detected strongly in the GC(-), while Th2 and Tfh-related molecules were detected in the GC(+). In contrast, no significant association with strong lymphocytic infiltration was observed in T(reg)-related molecules. These results indicate that SS has selective localization of Th subsets such as Th1, Th2, Th17 and Tfh in the LSGs, which is associated closely with disease severity and/or status. SS might be initiated by Th1 and Th17 cells, and then progressed by Th2 and Tfh cells via GC formation.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006377 T-Lymphocytes, Helper-Inducer Subpopulation of CD4+ lymphocytes that cooperate with other lymphocytes (either T or B) to initiate a variety of immune functions. For example, helper-inducer T-cells cooperate with B-cells to produce antibodies to thymus-dependent antigens and with other subpopulations of T-cells to initiate a variety of cell-mediated immune functions. Helper Cell,Helper Cells,Helper T Cell,Helper-Inducer T-Lymphocytes,Inducer Cell,Inducer Cells,T-Cells, Helper-Inducer,T-Lymphocytes, Helper,T-Lymphocytes, Inducer,Helper T-Cells,Cell, Helper T,Cells, Helper T,Helper Inducer T Lymphocytes,Helper T Cells,Helper T-Cell,Helper T-Lymphocyte,Helper T-Lymphocytes,Helper-Inducer T-Cell,Helper-Inducer T-Cells,Helper-Inducer T-Lymphocyte,Inducer T-Lymphocyte,Inducer T-Lymphocytes,T Cell, Helper,T Cells, Helper,T Cells, Helper Inducer,T Lymphocytes, Helper,T Lymphocytes, Helper Inducer,T Lymphocytes, Inducer,T-Cell, Helper,T-Cell, Helper-Inducer,T-Cells, Helper,T-Lymphocyte, Helper,T-Lymphocyte, Helper-Inducer,T-Lymphocyte, Inducer
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D012470 Salivary Glands, Minor Accessory salivary glands located in the lip, cheek, tongue, floor of mouth, palate and intramaxillary. Gland, Minor Salivary,Glands, Minor Salivary,Minor Salivary Gland,Minor Salivary Glands,Salivary Gland, Minor

Related Publications

T Maehara, and M Moriyama, and J-N Hayashida, and A Tanaka, and S Shinozaki, and Y Kubo, and K Matsumura, and S Nakamura
January 1992, Autoimmunity,
T Maehara, and M Moriyama, and J-N Hayashida, and A Tanaka, and S Shinozaki, and Y Kubo, and K Matsumura, and S Nakamura
January 2014, Mediators of inflammation,
T Maehara, and M Moriyama, and J-N Hayashida, and A Tanaka, and S Shinozaki, and Y Kubo, and K Matsumura, and S Nakamura
January 1997, Journal of immunology (Baltimore, Md. : 1950),
T Maehara, and M Moriyama, and J-N Hayashida, and A Tanaka, and S Shinozaki, and Y Kubo, and K Matsumura, and S Nakamura
April 1996, The Journal of clinical investigation,
T Maehara, and M Moriyama, and J-N Hayashida, and A Tanaka, and S Shinozaki, and Y Kubo, and K Matsumura, and S Nakamura
January 1995, Ocular immunology and inflammation,
T Maehara, and M Moriyama, and J-N Hayashida, and A Tanaka, and S Shinozaki, and Y Kubo, and K Matsumura, and S Nakamura
March 1985, Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology,
T Maehara, and M Moriyama, and J-N Hayashida, and A Tanaka, and S Shinozaki, and Y Kubo, and K Matsumura, and S Nakamura
March 1974, The Bulletin of Tokyo Medical and Dental University,
T Maehara, and M Moriyama, and J-N Hayashida, and A Tanaka, and S Shinozaki, and Y Kubo, and K Matsumura, and S Nakamura
November 1999, International journal of molecular medicine,
T Maehara, and M Moriyama, and J-N Hayashida, and A Tanaka, and S Shinozaki, and Y Kubo, and K Matsumura, and S Nakamura
January 1999, Clinical and experimental rheumatology,
T Maehara, and M Moriyama, and J-N Hayashida, and A Tanaka, and S Shinozaki, and Y Kubo, and K Matsumura, and S Nakamura
April 2004, The Journal of pathology,
Copied contents to your clipboard!